Companies: 10,795·Total market cap: $144.5T
Nanobiotix S.A.

Nanobiotix S.A.

NBTXNASDAQHealthcare● Active
$35.88
+$0.42(+1.18%)
Market Cap$1.8B
P/E Ratio
52W High$57.14
52W Low$4.18
Overview

Nanobiotix S.A. (NBTX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

nbtx · stock forecast · 4 analysts (3M) · FMP · updated Apr 7, 2026

Analyst Rating & Consensus

Based on 4 Wall Street analysts in the past 3 months

SellBuy

Buy

4 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
Total: 4 · Buy rate: 75.0%

12-Month Price Target

High

$46.00

Consensus

$38.00

+5.9% upside

Low

$30.00

Median: $38 · Last Close: $35.88

The Nanobiotix S.A. (NBTX) analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month NBTX price target is $38.00, representing +5.9% upside from the current price of $35.88.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $38 (5.9%)

Consensus Target

$38.00

5.9% upside

High Target

$46

28.2%

Low Target

$30

-16.4%

Current Price

$35.88

as of today

Based on analyst price targets, the NBTX stock price prediction for the next 12 months ranges from $30 to $46. The consensus NBTX price forecast of $38.00 implies 5.9% upside from the current price of $35.88.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$34.095.00%

1-day model range: $33.63–$34.54. Peak: $34.54 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$70+94.5%
2028$106+195.5%
2029$136+279.9%
2030$158+339.6%
2031+377.6%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

36%0%64%
5Buy
0Neutral
9Sell
RSI (14)15.2Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NBTX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$36.04SELL
MA 10$38.03SELL
MA 20$43.04SELL
MA 50$37.24SELL
MA 100$32.12BUY
MA 200$25.44BUY
Current $NBTX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$36.48SELL
EMA 10$38.02SELL
EMA 20$39.39SELL
EMA 50$37.56SELL
EMA 100$33.26BUY
EMA 200$26.71BUY
Current $NBTX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Leerink Partners2026-06-04
Maintains
OutperformOutperform
UBS2026-05-01
Maintains
NeutralNeutral
Guggenheim2026-04-02
Maintains
BuyBuy
Guggenheim2026-02-06
Maintains
BuyBuy
Guggenheim2025-04-04
Maintains
BuyBuy
Evercore ISI Group2021-01-06
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Nanobiotix S.A. (NBTX) stock. Of the recent 6 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover NBTX.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

NBTX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$34M

↓ 63.6% YoY

Revenue Next Year

$58M

↑ 67.4% YoY

EPS This Year

$-0.20

EPS Next Year

$-0.08

↓ 58.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NBTX EPS of $-0.20 for the current fiscal year, based on estimates from 3 analysts. The NBTX revenue forecast is $34M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NBTX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NBTX price target is $38.00 (+5.9% upside), with an analyst consensus of Buy.

The NBTX short-term stock prediction for tomorrow is $34.09 (-5.00%). The NBTX stock price prediction for 2027 estimates an average of $70. The NBTX stock prediction for 2030 projects a range of $135–$181.

Nanobiotix S.A. trades on NASDAQ under the ticker NBTX. The NBTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NBTX forecast · 8 questions

According to 4 Wall Street analysts, the average 12-month NBTX price target is $38.00, with a high forecast of $46.00 and a low of $30.00. The median price target is shown in the chart above when available. This implies +5.9% potential upside from the current price of $35.88.

NBTX price targetWhat is NBTX price targetNBTX analyst price targetNBTX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.